Home › Upcoming votes › INTEGRATED BIOPHARMA INC
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in INTEGRATED BIOPHARMA INC’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | ELECTION OF DIRECTORS Director election |
Board | For | 99.1% support for the one nominee |
| 2 | RATIFICATION OF THE COMPANY'S 2025 EQUITY INCENTIVE PLAN ADOPTED ON DECEMBER 9, 2025 | Board | For | — |
| 3 | RATIFICATION OF THE APPOINTMENT OF INDEPENDENT AUDITOR Auditor |
Board | For | 99.4% support |
From INTEGRATED BIOPHARMA INC’s Form 8-K, filed December 1, 2025, for the meeting held December 1, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Eric Friedman | 99.1% | — |
| 3. Non-binding advisory vote on Executive Compensation The Company's stockholders voted, by a non-binding advisory vote for the Executive Co | 99.7% | — |
| 4. To ratify the appointment of the Company ' s independent auditors for the fiscal year ending June 30, 2026 | 99.4% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.